FLGT Q1 2024 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$458M

Q1 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$64M-2.5% YoY

Gross Profit

$22M34.3% margin

Operating Income

-$22M-33.8% margin

Net Income

-$13M-20.9% margin

EPS (Diluted)

$-0.45

QoQ Revenue Growth

-8.5%

Cash Flow

Operating Cash Flow

$7M

Free Cash Flow

$3M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$103M

Stockholders' Equity

$1.1B

Cash & Equivalents

$55M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$64M	$66M	-2.5%
Gross Profit	$22M	$19M	+17.5%
Operating Income	-$22M	-$25M	+12.2%
Net Income	-$13M	-$15M	+12.2%

Revenue Segments

Laboratory Services

$64M100%

Geographic Segments

UNITED STATES

$58M90%

CHINA

$4M6%

Other Countries

$3M4%